NDA[removed]S-050 NDA[removed]S-035 NDA[removed]S-033 FDA Approved Labeling Text dated[removed]Page 1

First Page		Document Content
Date: 2011-08-11 15:22:55 Anticonvulsants Gabapentin Chemistry Neurology Amines Postherpetic neuralgia Neuropathic pain Epilepsy Medicine Pfizer Analgesics		NDA[removed]S-050 NDA[removed]S-035 NDA[removed]S-033 FDA Approved Labeling Text dated[removed]Page 1 Add to Reading List Source URL: www.accessdata.fda.gov Download Document from Source Website File Size: 202,82 KB Share Document on Facebook

	Pain Physician 2016; 19:E121-E128 • ISSNProspective Evaluation A Novel Mini-invasive Approach to the Treatment of Neuropathic Pain: The PENS Study DocID: 1u8Bv - View Document
	Pain Medicine 2011; 12: 1515–1522 Wiley Periodicals, Inc. NEUROPATHIC PAIN SECTION Original Research Articles Randomized Double-Blind Sham-Controlled DocID: 1tU4Z - View Document
	Neuropathic pain in Palliative Care How do we treat it and do we really know what we are doing? DocID: 1ri9T - View Document
	4\|P age Alcoholic extract of Banaba leaf prevents chronic constriction injury induced neuropathic pain in experimental animals KIRAN HARIBHAU BHOKARE , AMAN BABANRAO 1 DocID: 1r9Kd - View Document
	Regulation of Spinal Fractalkine/CX3CR1 and TNF-alpha Signaling in Paclitaxel Induced Peripheral Neuropathy in Rats Chemotherapy-induced peripheral neuropathy (CIPN) is a common, potentially severe and dose-limiting adve DocID: 1qSei - View Document